These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18284101)

  • 21. Treatments for methamphetamine abuse: a literature review for the clinician.
    Brackins T; Brahm NC; Kissack JC
    J Pharm Pract; 2011 Dec; 24(6):541-50. PubMed ID: 22095579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An emerging problem: methamphetamine abuse among treatment seeking youth.
    Gonzales R; Ang A; McCann MJ; Rawson RA
    Subst Abus; 2008; 29(2):71-80. PubMed ID: 19042326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychological Burden and Gender Differences in Methamphetamine-Dependent Individuals in Treatment.
    Simpson JL; Grant KM; Daly PM; Kelley SG; Carlo G; Bevins RA
    J Psychoactive Drugs; 2016; 48(4):261-9. PubMed ID: 27541988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of methamphetamine abuse treatment: Predictors of treatment completion and comparison of two residential treatment programs.
    Kamp F; Proebstl L; Hager L; Schreiber A; Riebschläger M; Neumann S; Straif M; Schacht-Jablonowsky M; Manz K; Soyka M; Koller G
    Drug Alcohol Depend; 2019 Aug; 201():8-15. PubMed ID: 31154239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying methamphetamine users at risk for major depressive disorder: findings from the methamphetamine treatment project at three-year follow-up.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
    Am J Addict; 2008; 17(2):99-102. PubMed ID: 18393051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychological function and delay discounting in methamphetamine-dependent individuals.
    Hoffman WF; Moore M; Templin R; McFarland B; Hitzemann RJ; Mitchell SH
    Psychopharmacology (Berl); 2006 Oct; 188(2):162-70. PubMed ID: 16915378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The methamphetamine epidemic: implications for HIV prevention and treatment.
    Colfax G; Shoptaw S
    Curr HIV/AIDS Rep; 2005 Nov; 2(4):194-9. PubMed ID: 16343378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychiatric comorbidity of methamphetamine dependence in a forensic sample.
    Kalechstein AD; Newton TF; Longshore D; Anglin MD; van Gorp WG; Gawin FH
    J Neuropsychiatry Clin Neurosci; 2000; 12(4):480-4. PubMed ID: 11083165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Why do we need an Addiction supplement focused on methamphetamine?
    Rawson RA; Condon TP
    Addiction; 2007 Apr; 102 Suppl 1():1-4. PubMed ID: 17493048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The scourge of methamphetamine.
    Thomas SP
    Issues Ment Health Nurs; 2009 Aug; 30(8):473. PubMed ID: 19591019
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prevalence and Therapy of Crystal Methamphetamine Dependence].
    Soyka M; Koller G; Proebstl L; Kamp F; Franke A; Schmidt P; Baumgärtner G; Schacht-Jablonowsky M; Sievert A; Straif M; Hamdorf W
    Fortschr Neurol Psychiatr; 2017 Feb; 85(2):92-99. PubMed ID: 28235211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Nothing Is Free": A Qualitative Study of Sex Trading Among Methamphetamine Users in Cape Town, South Africa.
    Watt MH; Kimani SM; Skinner D; Meade CS
    Arch Sex Behav; 2016 May; 45(4):923-33. PubMed ID: 25567071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beyond methamphetamine: Documenting the implementation of the Matrix model of substance use treatment for opioid users in a South African setting.
    Magidson JF; Gouse H; Burnhams W; Wu CY; Myers B; Joska JA; Carrico AW
    Addict Behav; 2017 Mar; 66():132-137. PubMed ID: 27940387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
    Longo M; Wickes W; Smout M; Harrison S; Cahill S; White JM
    Addiction; 2010 Jan; 105(1):146-54. PubMed ID: 19839966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methamphetamine use and dependence in vulnerable female populations.
    Kittirattanapaiboon P; Srikosai S; Wittayanookulluk A
    Curr Opin Psychiatry; 2017 Jul; 30(4):247-252. PubMed ID: 28426546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of methamphetamine abuse: research findings and clinical directions.
    Cretzmeyer M; Sarrazin MV; Huber DL; Block RI; Hall JA
    J Subst Abuse Treat; 2003 Apr; 24(3):267-77. PubMed ID: 12810148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amphetamine-type stimulant use among men who have sex with men (MSM) in Vietnam: Results from a socio-ecological, community-based study.
    Vu NT; Holt M; Phan HT; Le HT; La LT; Tran GM; Doan TT; Nguyen TN; de Wit J
    Drug Alcohol Depend; 2016 Jan; 158():110-7. PubMed ID: 26656138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The methamphetamine epidemic and dentistry.
    Klasser GD; Epstein JB
    Gen Dent; 2006; 54(6):431-9; quiz 440, 448. PubMed ID: 17134084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methamphetamine: geographic areas and populations at risk, and emerging evidence for effective interventions.
    Degenhardt L; Baker A; Maher L
    Drug Alcohol Rev; 2008 May; 27(3):217-9. PubMed ID: 18368601
    [No Abstract]   [Full Text] [Related]  

  • 40. Mediators of interpersonal violence and drug addiction severity among methamphetamine users in Cape Town, South Africa.
    Hobkirk AL; Watt MH; Green KT; Beckham JC; Skinner D; Meade CS
    Addict Behav; 2015 Mar; 42():167-71. PubMed ID: 25479528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.